Hh inhibition may mitigate the proliferative and cystogenic effects of cAMP, FSK and EGF, by possible crosstalk between Hh and ERK signaling, which has been observed in RCC and other cancers16,41,42. Here, EGF is linked to renal cell carcinoma.